sickle cell anemia

Global Blood Therapeutics Inc (NASDAQ: GBT), a clinical-stage biopharmaceutical company that develops therapeutics to treat blood-based disorders, received a breakthrough therapy designation in early January that has at least one analyst optimistic as to what will come next. The Analyst William...